Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Japanese Journal of Clinical Oncology|October 22, 2014
Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancerHarukaze Yamamoto, Masashi Ando, Kenjiro Aogi, et al.
BMC Cancer|February 14, 2018
Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary siteMakoto Kodaira, Kan Yonemori, Tatsunori Shimoi, et al.
Journal of Neuro-Oncology|July 24, 2008
Immunohistochemical profiles of brain metastases from breast cancerKan Yonemori, Koji Tsuta, Chikako Shimizu, et al.
Japanese Journal of Clinical Oncology|April 28, 2009
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case reportSatoru Iwasa, Masashi Ando, Makiko Ono, et al.
Global Health & Medicine|May 4, 2026
The Japanese version of the European Moral Case Deliberation Outcomes Instrument (Euro-MCD 2.0): Validation and score distribution among nurses, doctors, and other healthcare providers-A cross-sectional studyKaoru Ashida, Makoto Tanaka, Emi Kubo, et al.
Plos One|September 5, 2019
Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancerNatsuko Satomi-Tsushita, Akihiko Shimomura, Juntaro Matsuzaki, et al.
The Breast Journal|September 22, 2005
Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patientsTakashi Kanazawa, Sadako Akashi-Tanaka, Eriko Iwamoto, et al.
Clinical Breast Cancer|October 15, 2013
Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifenNobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, et al.
Pathology International|August 26, 2025
C-Myc Overexpression in Adolescent and Young Adult Breast Cancer: Distinct From Older Adults With Relevantly Expressed Cholecystokinin B ReceptorTomoyuki Tanino, Yoko Nakanishi, Haruna Nishimaki-Watanabe, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2016
Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancerSeiko Bun, Mayu Yunokawa, Takahiro Ebata, et al.
Pageof 23